Cyterix Pharmaceuticals Inc.

Changing dynamics in oncology, from increasing availability of generics to payors' unapologetic cost-consciousness, are influencing companies of all sizes. Recent start-up financings show support is a

In Vitro Diagnostics ACS Biomarker BV ACS Biomarker closes its Series A round ACS Biomarker BV (cardiovascular biomarkers) has raised an undisclosed amount through its Series A venture round. Life

Cyterix Pharmaceuticals Inc. Expecting enzymes to activate cancer drugs 1700 Owens Street Suite 500 San Francisco, CA 94158 Phone: (415) 865-2059 Web Site: www.cyterix.com Contact: Steven A. Everett,

Cancer Start-Ups: Upheaval and Opportunity Reshape the Oncology Market Cyterix Pharmaceuticals Inc. thinks it has found a way to safely increase the maximum tolerated dose of gemcitabine, a widely